Carsten Boess's Net Worth
$20.4 Million
Who is Carsten Boess?
Carsten Boess has an estimated net worth of $20.4 Million. This is based on reported shares across multiple companies, which include INSULET CORP, Kiniksa Pharmaceuticals, Ltd., Health Sciences Acquisitions Corp 2, ROCKET PHARMACEUTICALS, INC., Avidity Biosciences, Inc., ALEXION PHARMACEUTICALS INC, and SYNAGEVA BIOPHARMA CORP.
SEC CIK
Carsten Boess's CIK is 0001277495
Past Insider Trading and Trends
2011 was Carsten Boess's most active year for acquiring shares with 13 total transactions. Carsten Boess's most active month to acquire stocks was the month of May. 2007 was Carsten Boess's most active year for disposing of shares, totalling 77 transactions. Carsten Boess's most active month to dispose stocks was the month of November. 2015 saw Carsten Boess paying a total of $1,206,485.38 for 66,297 shares, this is the most they've acquired in one year. In 2014 Carsten Boess cashed out on 90,516 shares for a total of $3,860,609.58, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INSULET CORP (PODD) Snapshot price: $214.75
Vice President, International
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$14.79 | -$557,681.83 | 18.94K |
Scheduled
|
Apr 25
| ||
Form 4
|
—
|
0
|
$14.77 | -$80,760.00 | 18.94K |
Scheduled
|
Apr 18
| ||
Form 4
|
—
|
0
|
$14.30 | -$592,110.82 | 18.94K |
Scheduled
|
Mar 29 - Mar 30
| ||
Form 4
|
—
|
0
|
$13.82 | -$546,418.64 | 18.94K |
Scheduled
|
Mar 24 - Mar 25
| ||
Form 4
| +89.41% | 8.94K |
$17.49 | -$18,521.91 | 18.94K |
Mar 1
| |||
Form 4
|
—
|
0
|
$12.77 | -$47,829.76 | 10K |
Scheduled
|
Feb 7
| ||
Form 4
|
—
|
0
|
$12.64 | -$309,711.70 | 10K |
Scheduled
|
Feb 2
| ||
Form 4
|
—
|
0
|
$12.17 | -$111,266.76 | 10K |
Scheduled
|
Jan 18
| ||
Form 4
| -69.92% | -23.24K |
$15.03 | -$349,204.24 | 10K |
Scheduled
|
Oct 5
| ||
Form 4
| +43.03% | 10K |
—
|
—
| 33.24K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
∞
| 23.24K |
$5.07 | $117,826.80 | 23.24K |
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| -100.00% | -8.81K |
$16.17 | -$366,160.48 |
0
|
Scheduled
|
Dec 3 - Dec 5
| ||
Form 4
| -50.34% | -8.93K |
$23.93 | -$213,684.40 | 8.81K |
Scheduled
|
Dec 3
| ||
Form 4
|
∞
| 17.74K |
$16.37 | $21,728.45 | 17.74K |
Scheduled
|
Dec 3
| ||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $24.93
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.73% | 6.39K |
—
|
—
| 79.59K |
Feb 9 - May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Health Sciences Acquisitions Corp 2 (OBIO) Snapshot price: $5.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ROCKET PHARMACEUTICALS, INC. (RCKT) Snapshot price: $18.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avidity Biosciences, Inc. (RNA) Snapshot price: $40.46
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||